Total Payments
$315.74
2023 Payments
$25.38
Companies
11
Transactions
20
Medicare Patients
3,353
Medicare Billing
$263,880
Payment Breakdown by Category
Food & Beverage$315.74 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $315.74 | 20 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $90.43 | 6 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $58.91 | 4 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $28.53 | 2 | $0 (2017) |
| Supernus Pharmaceuticals, Inc. | $25.38 | 1 | $0 (2023) |
| Daiichi Sankyo Inc. | $22.68 | 1 | $0 (2019) |
| Promius Pharma LLC | $18.11 | 1 | $0 (2017) |
| PFIZER INC. | $18.00 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $17.52 | 1 | $0 (2018) |
| ABBVIE INC. | $12.72 | 1 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $12.58 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $25.38 | 1 | Supernus Pharmaceuticals, Inc. ($25.38) |
| 2022 | $30.72 | 2 | PFIZER INC. ($18.00) |
| 2019 | $22.68 | 1 | Daiichi Sankyo Inc. ($22.68) |
| 2018 | $17.52 | 1 | GlaxoSmithKline, LLC. ($17.52) |
| 2017 | $219.44 | 15 | Novo Nordisk Inc ($90.43) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/15/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $25.38 | General |
| Category: PSYCHOLOGY | ||||||
| 07/05/2022 | PFIZER INC. | PREVNAR 13 (Biological), PREVNAR 20, PAXLOVID | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: VACCINES | ||||||
| 04/14/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2019 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Anemia | ||||||
| 03/21/2018 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: VACCINES | ||||||
| 10/30/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2017 | Novo Nordisk Inc | Victoza (Drug), Xultophy 100/3.6, Tresiba | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: Diabetes | ||||||
| 09/11/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: RESPIRATORY | ||||||
| 08/15/2017 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Obesity | ||||||
| 08/08/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: RESPIRATORY | ||||||
| 08/01/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: RESPIRATORY | ||||||
| 05/15/2017 | Novo Nordisk Inc | Xultophy 100/3.6 (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Diabetes | ||||||
| 05/02/2017 | Promius Pharma LLC | Zembrace (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Neurology | ||||||
| 04/10/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: Diabetes | ||||||
| 04/10/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Diabetes | ||||||
| 03/27/2017 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/06/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI, STIOLTO | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: DIABETES | ||||||
| 02/27/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: DIABETES | ||||||
| 02/01/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: Diabetes | ||||||
| 01/31/2017 | SANOFI PASTEUR INC. | PENTACEL (Drug), FLUZONE HIGH-DOSE, FLUZONE | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 887 | 1,308 | $170,891 | $70,408 |
| 2022 | 15 | 907 | 1,327 | $156,539 | $75,147 |
| 2021 | 13 | 824 | 1,271 | $124,549 | $68,098 |
| 2020 | 12 | 735 | 1,080 | $107,407 | $50,227 |
Total Patients
3,353
Total Services
4,986
Medicare Billing
$263,880
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 205 | 397 | $94,573 | $29,796 | 31.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 163 | 163 | $26,080 | $20,144 | 77.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 65 | 67 | $8,040 | $4,789 | 59.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 16 | 16 | $13,851 | $4,205 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 57 | $9,601 | $2,870 | 29.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 198 | 310 | $5,270 | $2,577 | 48.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 80 | 82 | $2,132 | $2,089 | 98.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $2,530 | $1,739 | 68.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 14 | 16 | $1,353 | $553.92 | 41.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 14 | 30 | $2,979 | $486.60 | 16.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 16 | 16 | $688.00 | $473.28 | 68.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 11 | 11 | $385.00 | $240.90 | 62.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 16 | 24 | $1,398 | $228.48 | 16.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 17 | $1,105 | $150.78 | 13.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 17 | 91 | $905.85 | $64.78 | 7.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 207 | 428 | $82,038 | $33,185 | 40.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 155 | 155 | $24,800 | $19,581 | 79.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 17 | 17 | $13,059 | $4,727 | 36.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 68 | 68 | $8,108 | $4,545 | 56.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 18 | 18 | $4,132 | $2,904 | 70.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 48 | 51 | $6,370 | $2,725 | 42.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 15 | 15 | $3,450 | $2,421 | 70.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 75 | 76 | $2,252 | $1,999 | 88.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 207 | 307 | $5,219 | $916.61 | 17.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 22 | 22 | $826.30 | $630.72 | 76.3% |
About Dr. Jesus Trejo, MD
Dr. Jesus Trejo, MD is a Family Medicine healthcare provider based in Midlothian, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2011. The National Provider Identifier (NPI) number assigned to this provider is 1336434125.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jesus Trejo, MD has received a total of $315.74 in payments from pharmaceutical and medical device companies, with $25.38 received in 2023. These payments were reported across 20 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($315.74).
As a Medicare-enrolled provider, Trejo has provided services to 3,353 Medicare beneficiaries, totaling 4,986 services with total Medicare billing of $263,880. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Midlothian, TX
- Active Since 06/09/2011
- Last Updated 12/02/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1336434125
Products in Payments
- Victoza (Drug) $63.91
- UTIBRON (Drug) $58.91
- QELBREE (Drug) $25.38
- INJECTAFER (Drug) $22.68
- Zembrace (Drug) $18.11
- PREVNAR 13 (Biological) $18.00
- SHINGRIX (Biological) $17.52
- PRALUENT (Drug) $15.52
- Xultophy 100/3.6 (Drug) $14.61
- SOLIQUA (Drug) $13.01
- UBRELVY (Drug) $12.72
- JARDIANCE (Drug) $12.58
- Saxenda (Drug) $11.91
- PENTACEL (Drug) $10.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Midlothian
Donald Sanders, M.d, M.D
Family Medicine — Payments: $18,297
Family Medicine $18,297
Joseph Goddard, M.d, M.D
Family Medicine — Payments: $17,178
Family Medicine $17,178
Dr. Joseph Castro, D.o, D.O
Family Medicine — Payments: $14,548
Family Medicine $14,548
William Morrissette, M.d, M.D
Family Medicine — Payments: $13,896
Family Medicine $13,896
Dr. Laura Aisenberg, M.d, M.D
Family Medicine — Payments: $13,402
Family Medicine $13,402
Damian Covington, M. D, M. D
Family Medicine — Payments: $12,759
Family Medicine $12,759